Durvalumab: the new standard of care for NSCLC?

(1:24)

Durvalumab Tolerability in Non–Small Cell Lung Cancer

(4:25)

Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - Lung Cancer

(52:55)

The Use of Durvalumab in Locally Advanced NSCLC

(3:7)

Dr. Feldman on Durvalumab for Patients With Lung Cancer

(47)

Durvalumab - Imfinzi - All You Need to Know in 2 Minutes.

(2:49)

Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...

(4:33)

Durvalumab after chemoradiotherapy improves overall survival in lung cancer patients

(2:56)

Immune checkpoint inhibitors and their role in MM: pembrolizumab and durvalumab

(1:32)

Durvalumab (Imfinzi): How It Works, Benefits, and Side Effects Explained

(2:15)

NIAGARA Trial - Periop Durvalumab with Neoad Chemo Resectable Muscle-Invasive Bladder Cancer

(9:49)

Mickey and his caregiver, Carla, talk about IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl)

(9:10)

Current Management of Stage IIIA Non-Small Cell Lung Cancer: A Changing Paradigm (November 10, 2022)

(58:15)

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival ...

(7:6)

Consolidation Durvalumab Could Be New SOC in Limited-Stage SCLC

(5:8)

PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLC

(6:7)

#CancerNews: Terminal Bile Duct Cancer eradicated in an immunotherapy + chemotherapy combo trial

(1:49)

How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated

(2:44)

Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of Care? (BMIC-024)

(7:44)

AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer

(19:14)

Eden’s journey with IMFINZI® (durvalumab)

(4:4)

Dr. Langer on the Benefit of Durvalumab in Stage III NSCLC

(2:10)

MEDI1191 with durvalumab in advanced solid tumors

(1:16)

[lung]The role of durvalumab in patients with stage 3 lung cancer in a real hospital

(3:53)

The Mechanism of Action of Durvalumab in the Treatment of Urothelial Bladder Cancer

(1:6)

Durvalumab as a Consolidation Therapy for Locally Advanced NSCLC

(1:28)

Dr. Simon on Durvalumab for Patients With Lung Cancer

(1:20)

Durvalumab \u0026 olaparib as maintenance in patients with MMR-proficient advanced endometrial cancer

(32)

Durvalumab Following Chemoradiotherapy and Surgery

(2:26)

Imfinzi Uses: Guide to Understanding the Many Benefits of this Breakthrough Immunotherapy

(8:28)